SYLVIA GILLIS: Open Payments
NPI 1740876150 · BASEHOR, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 24 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $393 · 2025 $450
Food & beverage: $450
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $114 |
| ABBVIE INC. | 4 | $74 |
| Lilly USA, LLC | 3 | $58 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Amgen Inc. | 2 | $31 |
| Dexcom, Inc. | 1 | $31 |
| Globus Medical, Inc. | 1 | $25 |
| Viatris Specialty LLC | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Wegovy, MOUNJARO, Ozempic, UBRELVY, AUSTEDO XR, QULIPTA, ZORYVE, Dexcom G6 Transmitter.
Industry payments across KS — which companies pay providers there.
